Analysts Set LivaNova PLC (NASDAQ:LIVN) PT at $61.17

Shares of LivaNova PLC (NASDAQ:LIVN) have been given a consensus recommendation of “Moderate Buy” by the eight research firms that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $61.17.

A number of research analysts have recently weighed in on LIVN shares. The Goldman Sachs Group cut their price target on shares of LivaNova from $64.00 to $55.00 and set a “buy” rating on the stock in a report on Monday, March 3rd. Barclays cut their price target on shares of LivaNova from $58.00 to $56.00 and set an “equal weight” rating on the stock in a report on Friday, March 7th. Wolfe Research lowered shares of LivaNova from an “outperform” rating to a “peer perform” rating in a research note on Wednesday, February 26th. Mizuho lowered their target price on shares of LivaNova from $70.00 to $60.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 26th. Finally, StockNews.com lowered shares of LivaNova from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, February 26th.

Institutional Trading of LivaNova

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. grew its position in LivaNova by 17.1% in the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company’s stock worth $70,000 after purchasing an additional 219 shares during the last quarter. Sterling Capital Management LLC grew its position in LivaNova by 800.6% in the 4th quarter. Sterling Capital Management LLC now owns 1,621 shares of the company’s stock worth $75,000 after purchasing an additional 1,441 shares during the last quarter. Central Pacific Bank Trust Division boosted its position in shares of LivaNova by 21.2% during the 4th quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company’s stock valued at $191,000 after acquiring an additional 720 shares in the last quarter. Vestcor Inc acquired a new stake in shares of LivaNova during the 4th quarter valued at about $204,000. Finally, Optimize Financial Inc acquired a new stake in shares of LivaNova during the 4th quarter valued at about $208,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

LivaNova Stock Up 1.8 %

LivaNova stock opened at $39.24 on Thursday. The company has a market capitalization of $2.13 billion, a P/E ratio of 93.43 and a beta of 1.10. The firm’s fifty day simple moving average is $46.00 and its 200-day simple moving average is $49.07. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46. LivaNova has a 1-year low of $36.85 and a 1-year high of $64.47.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.